Director-General of NAFDAC, Prof. Mojisola Adeyeye has noted that Nigeria will continue with the solidarity trial of chloroquine for COVID-19 treatment. Adeyeye said on a television programme on Tuesday: “There is data to prove that hydroxychloroquine worked for many COVID-19 patients.
…As NCDC activates additional 2 labs, bringing total to 28 The National Agency for Food and Drug Administration and Control (NAFDAC) has said it will continue hydroxychloroquine clinical trials for COVID-19 treatment despite the suspension of the drug test by the World Health Organisation (WHO). The Director-General of the agency, Prof Mojisola Adeyeye, made this
Brazil’s health ministry said Monday it would not change its recommendation to treat coronavirus with hydroxychloroquine, despite the World Health Organization’s decision to suspend trials of the drug over safety concerns. Like his US counterpart Donald Trump, Brazilian President Jair Bolsonaro has touted the supposed benefits of hydroxychloroquine and a related drug,
Using the drug on COVID-19 patients could increase their likelihood of dying: WHO Geneva: The World Health Organization (WHO) said Monday that it had “temporarily” suspended clinical trials of hydroxychloriquine as a potential treatment for COVID-19 being carried out across a range of countries as a precautionary measure. Read Also: Panic as Buhari probes Abba